title: Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus.
authors.affiliation: Center for Drug Evaluation and Research, FDA, Rockville, Maryland 20850, USA. schiffenbaue@cder.fda.gov
authors.forename: Joel
authors.initials: J
authors.lastname: Schiffenbauer
authors.forename: Bevra
authors.initials: B
authors.lastname: Hahn
authors.forename: Michael H
authors.initials: MH
authors.lastname: Weisman
authors.forename: Lee S
authors.initials: LS
authors.lastname: Simon
mesh_terms: D015415:Biomarkers; D002986:Clinical Trials as Topic; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D017063:Outcome Assessment, Health Care; D012107:Research Design
chemical_list: D015415:Biomarkers